Furiex Pharmaceuticals, Inc. - FORM 10-K - EX-32.1 - CERTIFICATION OF CMO PURSUANT OT SECTION 906 OF THE SARBANES-OXLEY ACT - March 18, 2011

Attached files

file filename
10-K - FORM 10-K - Furiex Pharmaceuticals, Inc.d10k.htm
EX-23.1 - CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - Furiex Pharmaceuticals, Inc.dex231.htm
EX-21.1 - SUBSIDIARIES - Furiex Pharmaceuticals, Inc.dex211.htm
EX-31.1 - CERTIFICATION OF CMO PURSUANT OT SECTION 302 OF THE SARBANES-OXLEY ACT - Furiex Pharmaceuticals, Inc.dex311.htm
EX-31.2 - CERTIFICATION OF CFO PURSUANT OT SECTION 302 OF THE SARBANES-OXLEY ACT - Furiex Pharmaceuticals, Inc.dex312.htm
EX-32.2 - CERTIFICATION OF CFO PURSUANT OT SECTION 906 OF THE SARBANES-OXLEY ACT - Furiex Pharmaceuticals, Inc.dex322.htm

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of Furiex Pharmaceuticals, Inc. (the “Company”) on Form 10-K for the period ended December 31, 2010 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, June S. Almenoff, President and Chief Medical Officer (principal executive officer), of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, to my knowledge that:

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of, and for, the periods presented in the Report.

/s/ June S. Almenoff
June S. Almenoff
President and Chief Medical Officer
(principal executive officer)

March 18, 2011

Furiex Pharmaceuticals, Inc. Reports

Also read